Tag Archives: Kappos

Canada Patent Utility: Former USPTO Director Interview at BIO Convention

Photo credit to Meddy Garnet

David Kappos, former Director, US Patent and Trade Office and current Partner Cravath, Swaine and Moore, LLP discusses the Canadian Utility Requirement.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

Patent Utility Requirements for Biopharmaceutical Inventions: How Much is Enough?

Credit: Andrea Sivarsson

A debate between the innovative and generic perspectives on pharmaceutical patent law in Canada, moderated by David Kappos, will be held in Chicago on Monday April 22nd from 2:30-3:30pm in room S404A at this year’s BIO International Convention. Former Undersecretary of Commerce for Intellectual Property and USPTO Director David J. Kappos will moderate a panel of legal experts who will discuss recent developments in the area of patent utility and its implications for biopharmaceutical innovation.  Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , ,